A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Etoricoxib; Indomethacin

Criteria

Inclusion Criteria:

• Males or females at least 18 years of age who have acute gout.